Format

Send to

Choose Destination
Am J Pathol. 2002 Apr;160(4):1201-6.

Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation.

Author information

1
Department of Pathology and Laboratory Medicine, the Division of Anatomical Pathology, University of Pennsylvania, Philadelphia 19104-4283, USA.

Abstract

Although grafted cells may be promising therapy for stroke, survival of implanted neural cells in the brains of stroke patients has never been documented. Human NT2N (hNT) neurons derived from the NTera2 (NT2) teratocarcinoma cell line were shown to remain postmitotic, retain a neuronal phenotype, survive >1 year in host rodent brains and ameliorate motor and cognitive impairments in animal models of ischemic stroke. Here we report the first postmortem brain findings of a phase I clinical stroke trial patient implanted with human hNT neurons adjacent to a lacunar infarct 27 months after surgery. Neurofilament immunoreactive neurons were identified in the graft site, fluorescent in situ hybridization revealed polyploidy in groups of cells at this site just like polyploid hNT neurons in vitro, and there was no evidence of a neoplasm. These findings indicate that implanted hNT neurons survive for >2 years in the human brain without deleterious effects.

PMID:
11943704
PMCID:
PMC1867232
DOI:
10.1016/S0002-9440(10)62546-1
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center